James H M Brown
Research Subjects
James H M Brown has a total of 14 co-authors. Here are the top co-authors by number of shared publications:
- Gordon C. Bannister
Avon Orthopaedic Centre, Southmead Hospital, Bristol, UK
2 shared publications A. H. Taylor
Avon Orthopaedic Centre, Southmead Hospital, Westbury-on-Trim, Bristol BS10 5NB, UK
1 shared publication- A. M. Lovering
Bristol Centre for Antimicrobial Research and Evaluation, Microbiology Department, Southmead Hospital, North Bristol NHS Trust, Bristol BS10 5NB, UK
1 shared publication A. P. MacGowan
1 shared publicationA. W. Blom
Avon Orthopaedic Centre, Southmead Hospital, Westbury-on-Trim, Bristol, England
1 shared publicationB. J. A. Lankester
1 shared publication
Latest Publications
- Open Access
- 1 January 2020
- Published by ACT Publishing Group in International Journal of Orthopaedics
- Vol. 7 (3) , 1283-1288
Traction during Total Knee Arthroplasty Leads to a Bone-Conserving Tibial Resection: A Retrospective Comparative Study
Traction during Total Knee Arthroplasty leads to a Bone-Conserving Tibial Resection. A Retrospective Comparative Study
- 1 January 2020
- Published by ACT Publishing Group in International Journal of Orthopaedics
- Vol. 7 (3) , 1283-1288
Open AccessTraction during Total Knee Arthroplasty Leads to a Bone-Conserving Tibial Resection: A Retrospective Comparative Study
Traction during Total Knee Arthroplasty leads to a Bone-Conserving Tibial Resection. A Retrospective Comparative Study
- 1 July 2004
- Published by British Editorial Society of Bone & Joint Surgery in The Journal of Bone and Joint Surgery. British volume
- Vol. 86-B (5) , 688-691
Infection after total knee arthroplasty
The aim of our study was to determine the current incidence and outcome of infected total knee arthroplasty (TKA) in our unit comparing them with our earlier audit in 1986, which had revealed infection rates of 4.4% after 471 primary TKAs and 15% after 23 revision TKAs at a mean follow-up of 2.8 years. In the interim we introduced stringent antibiotic prophylaxis, and the routine use of occlusive clothing within vertical laminar flow theatres and 0.05% chlorhexidine lavage during arthroplasty surgery. We followed up 931 primary TKAs and 69 revision TKAs for a mean of 6.5 years (5 to 8). Patients were traced by postal questionnaire, telephone interview or examination of case notes of the deceased. Nine (1%) of the patients who underwent primary TKA, and four (5.8%) of those who underwent revision TKA developed deep infection. Two of nine patients (22.2%) who developed infection after primary TKA were successfully treated without further surgery. All four of the patients who had infection after revision TKA had a poor outcome with one amputation, one chronic discharging sinus and two arthrodeses. Patients who underwent an arthrodesis had comparable Oxford knee scores to those who underwent a two-stage revision. Although infection rates have declined with the introduction of prophylactic measures, and more patients are undergoing TKA, the outcome of infected TKA has improved very little.
- 1 July 2004
- Published by British Editorial Society of Bone & Joint Surgery in The Journal of Bone and Joint Surgery. British volume
- Vol. 86-B (5) , 688-691
Infection after total knee arthroplasty
The aim of our study was to determine the current incidence and outcome of infected total knee arthroplasty (TKA) in our unit comparing them with our earlier audit in 1986, which had revealed infection rates of 4.4% after 471 primary TKAs and 15% after 23 revision TKAs at a mean follow-up of 2.8 years. In the interim we introduced stringent antibiotic prophylaxis, and the routine use of occlusive clothing within vertical laminar flow theatres and 0.05% chlorhexidine lavage during arthroplasty surgery. We followed up 931 primary TKAs and 69 revision TKAs for a mean of 6.5 years (5 to 8). Patients were traced by postal questionnaire, telephone interview or examination of case notes of the deceased. Nine (1%) of the patients who underwent primary TKA, and four (5.8%) of those who underwent revision TKA developed deep infection. Two of nine patients (22.2%) who developed infection after primary TKA were successfully treated without further surgery. All four of the patients who had infection after revision TKA had a poor outcome with one amputation, one chronic discharging sinus and two arthrodeses. Patients who underwent an arthrodesis had comparable Oxford knee scores to those who underwent a two-stage revision. Although infection rates have declined with the introduction of prophylactic measures, and more patients are undergoing TKA, the outcome of infected TKA has improved very little.
- 1 January 2004
- Published by Elsevier in Foot and Ankle Surgery
- Vol. 10 (3) , 135-139
Early weight bearing is safe following arthroscopic ankle arthrodesis
- 1 January 2004
- Published by Elsevier in Foot and Ankle Surgery
- Vol. 10 (3) , 135-139
Early weight bearing is safe following arthroscopic ankle arthrodesis
- 1 December 2002
- Published by Elsevier in The Journal of Arthroplasty
- Vol. 17 (8) , 1006-1008
Early dislocation after total hip arthroplasty
- 1 December 2002
- Published by Elsevier in The Journal of Arthroplasty
- Vol. 17 (8) , 1006-1008
Early dislocation after total hip arthroplasty
- Open Access
- 1 July 2002
- Published by Oxford University Press (OUP) in Journal of Antimicrobial Chemotherapy
- Vol. 50 (1) , 73-77
Penetration of linezolid into bone, fat, muscle and haematoma of patients undergoing routine hip replacement
Twelve patients undergoing total hip replacement were given 600 mg of linezolid as a 20 min iv infusion along with conventional prophylaxis of 1 g of cefamandole immediately before surgery. Routine total hip arthroplasty was carried out, and at timed intervals during surgery samples of bone, fat, muscle and blood were collected for assay by high-performance liquid chromatography analysis. Samples of the haematoma fluid that formed around the operation site and further blood samples for assay were also collected at timed intervals following the operation. The penetration of linezolid into bone was rapid, with mean concentrations of 9.1 mg/L (95% CI 7.7–10.6 mg/L) achieved at 10 min after the infusion, decreasing to 6.3 mg/L (95% CI 3.9–8.6 mg/L) at 30 min. Correction for the simultaneous blood concentrations gave mean values for bone penetration of 51% at 10 min, 60% at 20 min and 47% at 30 min. Although the penetration of linezolid into fat was also rapid, mean concentrations and degree of penetration were c. 60% of those in bone; at 10 min they were 4.5 mg/L (95% CI 3.0–6.1 mg/L; penetration 27%); at 20 min they were 5.2 mg/L (95% CI 4.0–6.4 mg/L; penetration 37%); and at 30 min, 4.1 mg/L (95% CI 3.3–4.8 mg/L; penetration 31%). For muscle the corresponding values were 10.4 mg/L (95% CI 8.1–12.7 mg/L; penetration 58%) at 10 min, 13.4 mg/L (95% CI 10.2–16.5 mg/L; penetration 94%) at 20 min and 12.0 mg/L (95% CI 9.2–14.8 mg/L; penetration 93%) at 30 min. Mean concentrations of linezolid in the haematoma fluid drained from around the operation site were 8.2 mg/L at 6–8 h and 5.6 mg/L at 10–12 h after the infusion, and 7.0 mg/L at 2–4 h following a second 600 mg infusion given 12 h post-operatively. We conclude that linezolid exhibits rapid penetration into bone, fat and muscle of patients undergoing hip arthroplasty, to achieve levels in excess of its MIC for susceptible organisms (≤4 mg/L); therapeutic concentrations were maintained in the haematoma fluid that surrounds the operation site for >16 h.
- 1 July 2002
- Published by Oxford University Press (OUP) in Journal of Antimicrobial Chemotherapy
- Vol. 50 (1) , 73-77
Open AccessPenetration of linezolid into bone, fat, muscle and haematoma of patients undergoing routine hip replacement
Twelve patients undergoing total hip replacement were given 600 mg of linezolid as a 20 min iv infusion along with conventional prophylaxis of 1 g of cefamandole immediately before surgery. Routine total hip arthroplasty was carried out, and at timed intervals during surgery samples of bone, fat, muscle and blood were collected for assay by high-performance liquid chromatography analysis. Samples of the haematoma fluid that formed around the operation site and further blood samples for assay were also collected at timed intervals following the operation. The penetration of linezolid into bone was rapid, with mean concentrations of 9.1 mg/L (95% CI 7.7–10.6 mg/L) achieved at 10 min after the infusion, decreasing to 6.3 mg/L (95% CI 3.9–8.6 mg/L) at 30 min. Correction for the simultaneous blood concentrations gave mean values for bone penetration of 51% at 10 min, 60% at 20 min and 47% at 30 min. Although the penetration of linezolid into fat was also rapid, mean concentrations and degree of penetration were c. 60% of those in bone; at 10 min they were 4.5 mg/L (95% CI 3.0–6.1 mg/L; penetration 27%); at 20 min they were 5.2 mg/L (95% CI 4.0–6.4 mg/L; penetration 37%); and at 30 min, 4.1 mg/L (95% CI 3.3–4.8 mg/L; penetration 31%). For muscle the corresponding values were 10.4 mg/L (95% CI 8.1–12.7 mg/L; penetration 58%) at 10 min, 13.4 mg/L (95% CI 10.2–16.5 mg/L; penetration 94%) at 20 min and 12.0 mg/L (95% CI 9.2–14.8 mg/L; penetration 93%) at 30 min. Mean concentrations of linezolid in the haematoma fluid drained from around the operation site were 8.2 mg/L at 6–8 h and 5.6 mg/L at 10–12 h after the infusion, and 7.0 mg/L at 2–4 h following a second 600 mg infusion given 12 h post-operatively. We conclude that linezolid exhibits rapid penetration into bone, fat and muscle of patients undergoing hip arthroplasty, to achieve levels in excess of its MIC for susceptible organisms (≤4 mg/L); therapeutic concentrations were maintained in the haematoma fluid that surrounds the operation site for >16 h.